Jointown Pharmaceutical Group Past Earnings Performance
Past criteria checks 1/6
Jointown Pharmaceutical Group's earnings have been declining at an average annual rate of -3.2%, while the Healthcare industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 9.6% per year. Jointown Pharmaceutical Group's return on equity is 6.7%, and it has net margins of 1.4%.
Key information
-3.2%
Earnings growth rate
-2.1%
EPS growth rate
| Healthcare Industry Growth | 7.0% |
| Revenue growth rate | 9.6% |
| Return on equity | 6.7% |
| Net Margin | 1.4% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Jointown Pharmaceutical Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 149,205 | 2,047 | 7,247 | 163 |
| 30 Jun 24 | 147,953 | 2,039 | 7,010 | 176 |
| 31 Mar 24 | 148,519 | 2,151 | 7,153 | 202 |
| 31 Dec 23 | 150,140 | 2,174 | 7,325 | 197 |
| 30 Sep 23 | 151,842 | 2,170 | 7,586 | 190 |
| 30 Jun 23 | 151,797 | 2,159 | 7,589 | 184 |
| 31 Mar 23 | 147,366 | 2,194 | 7,233 | 176 |
| 31 Dec 22 | 140,424 | 2,085 | 6,798 | 178 |
| 30 Sep 22 | 133,260 | 1,782 | 6,436 | 203 |
| 30 Jun 22 | 128,411 | 1,545 | 6,226 | 215 |
| 31 Mar 22 | 124,929 | 2,141 | 6,192 | 210 |
| 31 Dec 21 | 122,407 | 2,448 | 6,196 | 195 |
| 30 Sep 21 | 122,634 | 3,339 | 6,109 | 179 |
| 30 Jun 21 | 121,491 | 3,988 | 6,144 | 151 |
| 31 Mar 21 | 116,315 | 3,258 | 6,008 | 139 |
| 31 Dec 20 | 110,860 | 3,075 | 5,775 | 127 |
| 30 Sep 20 | 106,438 | 2,849 | 5,609 | 87 |
| 30 Jun 20 | 102,417 | 2,242 | 5,344 | 82 |
| 31 Mar 20 | 102,007 | 1,976 | 5,198 | 73 |
| 31 Dec 19 | 99,497 | 1,727 | 5,134 | 74 |
| 30 Sep 19 | 96,769 | 1,588 | 5,110 | 74 |
| 30 Jun 19 | 93,116 | 1,547 | 4,883 | 79 |
| 31 Mar 19 | 89,589 | 1,446 | 4,820 | 78 |
| 31 Dec 18 | 87,136 | 1,341 | 4,669 | 76 |
| 30 Sep 18 | 83,230 | 1,262 | 4,459 | 73 |
| 30 Jun 18 | 80,163 | 1,189 | 4,278 | 101 |
| 31 Mar 18 | 77,339 | 1,481 | 4,154 | 86 |
| 31 Dec 17 | 73,943 | 1,446 | 3,894 | 73 |
| 30 Sep 17 | 70,783 | 1,374 | 3,660 | 48 |
| 30 Jun 17 | 67,999 | 1,360 | 3,439 | 0 |
| 31 Mar 17 | 64,925 | 921 | 3,131 | 0 |
| 31 Dec 16 | 61,557 | 877 | 2,957 | 0 |
| 30 Sep 16 | 58,367 | 777 | 2,745 | 0 |
| 30 Jun 16 | 55,482 | 754 | 2,596 | 0 |
| 31 Mar 16 | 53,091 | 718 | 2,434 | 0 |
| 31 Dec 15 | 49,589 | 695 | 2,288 | 0 |
| 30 Sep 15 | 46,895 | 640 | 2,159 | 0 |
| 30 Jun 15 | 45,049 | 602 | 2,061 | 0 |
| 31 Mar 15 | 43,171 | 566 | 1,975 | 0 |
| 31 Dec 14 | 41,068 | 561 | 1,813 | 0 |
| 30 Sep 14 | 39,273 | 533 | 1,670 | 0 |
| 30 Jun 14 | 37,189 | 509 | 1,546 | 0 |
| 31 Mar 14 | 35,150 | 493 | 1,411 | 0 |
| 31 Dec 13 | 33,438 | 478 | 1,325 | 0 |
Quality Earnings: 600998 has high quality earnings.
Growing Profit Margin: 600998's current net profit margins (1.4%) are lower than last year (1.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 600998's earnings have declined by 3.2% per year over the past 5 years.
Accelerating Growth: 600998's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 600998 had negative earnings growth (-5.7%) over the past year, making it difficult to compare to the Healthcare industry average (-5.7%).
Return on Equity
High ROE: 600998's Return on Equity (6.7%) is considered low.